SHREE GANESH REMEDIES
Back to Balance Sheet
|
SHREE GANESH REMEDIES Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2020 | Mar2019 | |
|---|---|---|---|---|
| Contingent Liabilities | ₹5.21 Cr | ₹4.97 Cr | - | - |
What is the latest Contingent Liabilities ratio of SHREE GANESH REMEDIES ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹5.21 Cr |
| Mar2024 | ₹4.97 Cr |
| Mar2020 | - |
| Mar2019 | - |
How is Contingent Liabilities of SHREE GANESH REMEDIES Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹5.21 Cr | 4.87 | |
| Mar2024 | ₹4.97 Cr | 0 | |
| Mar2020 | - | 0 | |
| Mar2019 | - | - | |
Compare Contingent Liabilities of peers of SHREE GANESH REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SHREE GANESH REMEDIES | ₹659.8 Cr | 1.6% | 3.1% | -27.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹400,497.0 Cr | -1.4% | -6.2% | -1.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹166,939.0 Cr | -0.1% | 2.3% | 9.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹138,109.0 Cr | -1.8% | -4.9% | 28.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,578.0 Cr | -0.4% | -6% | 5.3% | Stock Analytics | |
| CIPLA | ₹99,761.1 Cr | 0.4% | -2.6% | -17.6% | Stock Analytics | |
SHREE GANESH REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SHREE GANESH REMEDIES | 1.6% |
3.1% |
-27.4% |
| SENSEX | 0.5% |
3.2% |
2.3% |
You may also like the below Video Courses